PMS2 and cancer: Previous work and our mutation spectrum data suggest that cancers triggered by EXO1 deficiency will rarely display microsatellite instability [41, 45, 60] (Figs 3 and 4), which is a hallmark of MMR deficiency caused by MSH2, MLH1, or PMS2 inactivation.